New Directors are Named at Five AACI Cancer Centers

AACI congratulates the following five new cancer center directors: Carlos L. Arteaga, MD, Harold C. Simmons Comprehensive Cancer Center at UT Southwestern; Jason Chesney, MD, PhD, UofL Brown Cancer Center; Ramon Parsons, MD, PhD, The Tisch Cancer Institute at the Mount Sinai Health System; Peter Pisters, MD, University of Texas MD Anderson Cancer Center; and, Michael Teitell, MD, PhD, UCLA Jonsson Comprehensive Cancer Center.

Dr. Arteaga is recognized for his work in laboratory-based translational research and advancing the care of breast cancer patients. His appointment at Simmons Comprehensive Cancer Center began September 1 and he joined UT Southwestern from the Vanderbilt-Ingram Cancer Center, in Nashville, Tennessee, where he had been on faculty since 1989. Dr. Arteagaís recruitment to UT Southwestern was facilitated by a $6 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).

Dr. Chesney joined the University of Louisville in 2003 and has served as associate director for translational research, director of the centerís cancer trials program and the biorepository, and director of the joint James Graham Brown Cancer Center and Clinical Translational Research Biorepository, Catholic Health Initiatives Institute for Research and Innovation. Over the past 10 years, Dr. Chesneyís research group has discovered the roles of several metabolic enzymes in the development and progression of lung cancer, including 6-phosphofructo-2-kinase 3, choline kinase and cytochrome c oxidase.

Dr. Parsons became director of The Tisch Cancer Institute on July 1. Prior to joining the Ichan School of Medicine at Mt. Sinai in 2013 he served on the Columbia College of Physicians and Surgeons faculty for 18 years. As Tisch director, Dr. Parsons will oversee scientific development and encourage collaborations among cancer investigators. Important priorities will be maintaining the Instituteís National Cancer Institute designation and working towards designation as a Comprehensive Cancer Center. He will also continue his own research program on the identification of genetic and biochemical changes that lead normal cells to develop into cancerous ones.

MD Andersonís new director, Dr. Pisters, is a cancer surgeon, researcher, professor and hospital administrator, who most recently served as President and Chief Executive Officer of University Health Network in Toronto, Canada, which includes AACI member Princess Margaret Cancer Centre. Dr. Pisters served in multiple roles from 1994 to 2014 at MD Anderson, including as Medical Director of its five regional cancer centers, clinical consultant for the Center for Global Oncology (now known as MD Anderson Cancer Network), and section chief for sarcoma surgery with a specialty focus in the management of sarcoma and gastrointestinal cancer patients.

Dr. Teitellís appointment as director of the UCLA Jonsson Comprehensive Cancer Center became effective August 8. A molecular immunologist and biochemist, Dr. Teitell has been a member of the faculty at the David Geffen School of Medicine at UCLA since 1999. He has served as co-director of the UCLA Tumor Immunology Training Program, co-director of the Broad Stem Cell Research Center Bioengineering Core, and an associate director of the UCLA-Caltech Medical Scientist Training Program.